DK3909972T3 - Pd1-cd28-fusionsproteiner og disses anvendelse i medicin - Google Patents
Pd1-cd28-fusionsproteiner og disses anvendelse i medicin Download PDFInfo
- Publication number
- DK3909972T3 DK3909972T3 DK21155542.0T DK21155542T DK3909972T3 DK 3909972 T3 DK3909972 T3 DK 3909972T3 DK 21155542 T DK21155542 T DK 21155542T DK 3909972 T3 DK3909972 T3 DK 3909972T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicine
- fusion proteins
- fusion
- proteins
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15172913 | 2015-06-19 | ||
| EP16736802.6A EP3310805B1 (en) | 2015-06-19 | 2016-06-20 | Pd-1-cd28 fusion proteins and their use in medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3909972T3 true DK3909972T3 (da) | 2024-04-29 |
| DK3909972T5 DK3909972T5 (da) | 2024-08-05 |
Family
ID=53476720
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21155542.0T DK3909972T5 (da) | 2015-06-19 | 2016-06-20 | Pd1-cd28-fusionsproteiner og disses anvendelse i medicin |
| DK16736802.6T DK3310805T3 (da) | 2015-06-19 | 2016-06-20 | Pd-1-cd28-fusionsproteiner og anvendelse deraf i medicin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16736802.6T DK3310805T3 (da) | 2015-06-19 | 2016-06-20 | Pd-1-cd28-fusionsproteiner og anvendelse deraf i medicin |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11192935B2 (da) |
| EP (3) | EP3909972B1 (da) |
| JP (3) | JP7085988B2 (da) |
| CN (3) | CN108026151B (da) |
| AU (1) | AU2016277883B2 (da) |
| CA (1) | CA2989949A1 (da) |
| DK (2) | DK3909972T5 (da) |
| ES (2) | ES2976647T3 (da) |
| FI (1) | FI3909972T3 (da) |
| HU (1) | HUE054201T2 (da) |
| PL (1) | PL3310805T3 (da) |
| PT (1) | PT3310805T (da) |
| WO (1) | WO2016203048A1 (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2979088T3 (es) | 2015-03-05 | 2024-09-24 | Fred Hutchinson Cancer Center | Proteínas de fusión inmunomoduladoras y usos de las mismas |
| CA2986254A1 (en) | 2015-05-18 | 2016-11-24 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| PT3310805T (pt) * | 2015-06-19 | 2021-05-19 | Kobold Sebastian | Proteínas de fusão pd-1-cd28 e a sua utilização em medicina |
| KR20180038447A (ko) * | 2015-06-29 | 2018-04-16 | 더 존스 홉킨스 유니버시티 | 면역 체크포인트 키메라 수용체 치료법 |
| CN105331585A (zh) * | 2015-11-13 | 2016-02-17 | 科济生物医药（上海）有限公司 | 携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 |
| EP3433269B1 (en) * | 2016-03-23 | 2023-09-27 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins of pd-1 and 4-1bb |
| CN107523545A (zh) * | 2016-06-20 | 2017-12-29 | 上海细胞治疗研究院 | 一种高效稳定表达抗体的杀伤性细胞及其用途 |
| AU2017291262A1 (en) * | 2016-06-30 | 2019-01-03 | F. Hoffmann-La Roche Ag | Improved adoptive T-cell therapy |
| WO2018026953A1 (en) | 2016-08-02 | 2018-02-08 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| KR20190058509A (ko) | 2016-10-07 | 2019-05-29 | 티씨알2 테라퓨틱스 인크. | 융합 단백질을 이용하는 t-세포 수용체 리프로그래밍을 위한 조성물 및 방법 |
| CA3044593A1 (en) | 2016-11-22 | 2018-05-31 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| JP2020513754A (ja) * | 2016-12-21 | 2020-05-21 | ティーシーアール２ セラピューティクス インク． | がん治療用に操作されたｔ細胞 |
| ES2912408T3 (es) * | 2017-01-26 | 2022-05-25 | Novartis Ag | Composiciones de CD28 y métodos para terapia con receptores quiméricos para antígenos |
| MX2019010812A (es) | 2017-03-17 | 2019-12-11 | Hutchinson Fred Cancer Res | Proteinas de fusion inmunomoduladoras y sus usos. |
| CA3093078A1 (en) * | 2018-03-06 | 2019-09-12 | The Trustees Of The University Of Pennsylvania | Prostate-specific membrane antigen cars and methods of use thereof |
| CN108727504B (zh) * | 2018-04-16 | 2021-08-27 | 泉州向日葵生物科技有限公司 | 一种ifn与抗pd-l1抗体的融合蛋白及其应用 |
| CN111606999B (zh) * | 2019-02-26 | 2022-09-06 | 南京惟亚德生物医药有限公司 | 兼具激活免疫共刺激信号通路和阻断免疫检查点的复制型溶瘤腺病毒及其应用 |
| EP3999079A4 (en) * | 2019-07-19 | 2024-04-03 | Memorial Sloan Kettering Cancer Center | FUSION POLYPEPTIDE FOR IMMUNOTHERAPY |
| CN113832114A (zh) * | 2020-06-23 | 2021-12-24 | 南京大学 | 一种新型溶瘤腺病毒EM/VSV-G Ad5-P及其在制备抗肿瘤药物中的应用 |
| CN113832111A (zh) * | 2020-06-23 | 2021-12-24 | 南京大学 | 一种类外泌体技术用于制备新型溶瘤病毒的方法 |
| CN115197314A (zh) * | 2021-04-11 | 2022-10-18 | 中国科学院分子细胞科学卓越创新中心 | 一种pd1变体及其用途 |
| EP4340862A2 (en) * | 2021-05-20 | 2024-03-27 | Achelois Biopharma, Inc. | Immune checkpoint multivalent particles compositions and methods of use |
| WO2023235479A1 (en) * | 2022-06-02 | 2023-12-07 | TCR2 Therapeutics Inc. | Compositions and methods for treating cancer |
| WO2024107577A2 (en) * | 2022-11-14 | 2024-05-23 | Achelois Biopharma, Inc. | Immune checkpoint multivalent particles compositions and methods of use |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19822115B4 (de) | 1998-05-08 | 2004-04-08 | Heinrich-Pette-Institut | Retrovirale Gentransfervektoren |
| US8003770B2 (en) | 2005-09-13 | 2011-08-23 | Mie University | T-cell receptor and nucleic acid encoding the receptor |
| EP2318434A1 (en) | 2008-07-31 | 2011-05-11 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Her2/neu specific t cell receptors |
| ZA200807283B (en) | 2008-08-22 | 2009-10-28 | Mechlift Invest Pty Ltd | Data unit for a bin lifting device |
| SG190997A1 (en) | 2010-12-09 | 2013-07-31 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| JP6076963B2 (ja) | 2011-04-08 | 2017-02-15 | アメリカ合衆国 | 抗上皮成長因子受容体変異体ｉｉｉキメラ抗原受容体及び癌の治療のためのその使用 |
| CN107266584B (zh) * | 2011-07-29 | 2022-05-13 | 宾夕法尼亚大学董事会 | 转换共刺激受体 |
| JP6267644B2 (ja) | 2011-10-20 | 2018-01-24 | アメリカ合衆国 | 抗ｃｄ２２キメラ抗原受容体 |
| WO2013062365A2 (ko) * | 2011-10-26 | 2013-05-02 | 국립암센터 | 변이 ｃｔｌａ4 유전자 이입 ｔ 세포 및 이를 포함하는 항암 면역치료용 조성물 |
| US9688740B2 (en) * | 2011-10-26 | 2017-06-27 | National Cancer Center | Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapy |
| WO2013142034A1 (en) | 2012-03-23 | 2013-09-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-mesothelin chimeric antigen receptors |
| EA033110B1 (ru) | 2012-04-11 | 2019-08-30 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерный рецептор антигена, направленный на антиген созревания b-клеток, кодирующая его нуклеиновая кислота, соответствующие экспрессионный вектор, клетка-хозяин, применения и способы |
| GB201206559D0 (en) | 2012-04-13 | 2012-05-30 | Ucl Business Plc | Polypeptide |
| US9657105B2 (en) | 2013-03-15 | 2017-05-23 | City Of Hope | CD123-specific chimeric antigen receptor redirected T cells and methods of their use |
| TWI654206B (zh) | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
| DK3039040T3 (da) | 2013-08-26 | 2022-02-07 | Hinrich Abken | Kimær anti cd30-antigenreceptor og anvendelse deraf |
| EP3227317A4 (en) | 2014-12-02 | 2018-04-25 | Roger Williams Hospital | Methods and compositons for treating cancer |
| PT3310805T (pt) | 2015-06-19 | 2021-05-19 | Kobold Sebastian | Proteínas de fusão pd-1-cd28 e a sua utilização em medicina |
| CA3071661A1 (en) | 2017-09-06 | 2019-03-14 | Fred Hutchinson Cancer Research Center | Strep-tag specific chimeric receptors and uses thereof |
| CN115418362A (zh) * | 2019-12-02 | 2022-12-02 | 吉林凯莱英医药化学有限公司 | 共固定化酶、其制备方法及其应用 |
-
2016
- 2016-06-20 PT PT167368026T patent/PT3310805T/pt unknown
- 2016-06-20 WO PCT/EP2016/064195 patent/WO2016203048A1/en unknown
- 2016-06-20 DK DK21155542.0T patent/DK3909972T5/da active
- 2016-06-20 PL PL16736802T patent/PL3310805T3/pl unknown
- 2016-06-20 JP JP2018517487A patent/JP7085988B2/ja active Active
- 2016-06-20 DK DK16736802.6T patent/DK3310805T3/da active
- 2016-06-20 CN CN201680048221.3A patent/CN108026151B/zh active Active
- 2016-06-20 ES ES21155542T patent/ES2976647T3/es active Active
- 2016-06-20 EP EP21155542.0A patent/EP3909972B1/en active Active
- 2016-06-20 US US15/737,877 patent/US11192935B2/en active Active
- 2016-06-20 FI FIEP21155542.0T patent/FI3909972T3/fi active
- 2016-06-20 CA CA2989949A patent/CA2989949A1/en active Pending
- 2016-06-20 AU AU2016277883A patent/AU2016277883B2/en active Active
- 2016-06-20 CN CN202210854297.2A patent/CN115925971A/zh active Pending
- 2016-06-20 ES ES16736802T patent/ES2870174T3/es active Active
- 2016-06-20 EP EP24156660.3A patent/EP4349854A3/en active Pending
- 2016-06-20 EP EP16736802.6A patent/EP3310805B1/en active Active
- 2016-06-20 HU HUE16736802A patent/HUE054201T2/hu unknown
- 2016-06-20 CN CN202210834160.0A patent/CN115927474A/zh active Pending
-
2021
- 2021-10-29 US US17/515,250 patent/US20220169699A1/en active Pending
-
2022
- 2022-03-22 JP JP2022044885A patent/JP7460675B2/ja active Active
-
2024
- 2024-03-21 JP JP2024044396A patent/JP2024073636A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7460675B2 (ja) | 2024-04-02 |
| EP3310805A1 (en) | 2018-04-25 |
| EP3310805B1 (en) | 2021-02-17 |
| JP2018518990A (ja) | 2018-07-19 |
| EP3909972B1 (en) | 2024-02-14 |
| CN115927474A (zh) | 2023-04-07 |
| ES2870174T3 (es) | 2021-10-26 |
| DK3310805T3 (da) | 2021-05-03 |
| US20220169699A1 (en) | 2022-06-02 |
| EP4349854A3 (en) | 2024-07-10 |
| PL3310805T3 (pl) | 2021-08-23 |
| CN115925971A (zh) | 2023-04-07 |
| ES2976647T3 (es) | 2024-08-06 |
| EP3909972A1 (en) | 2021-11-17 |
| US11192935B2 (en) | 2021-12-07 |
| CN108026151B (zh) | 2022-07-15 |
| JP2024073636A (ja) | 2024-05-29 |
| AU2016277883A1 (en) | 2018-01-18 |
| JP2022084787A (ja) | 2022-06-07 |
| JP7085988B2 (ja) | 2022-06-17 |
| CN108026151A (zh) | 2018-05-11 |
| CA2989949A1 (en) | 2016-12-22 |
| WO2016203048A1 (en) | 2016-12-22 |
| AU2016277883A8 (en) | 2018-01-25 |
| HUE054201T2 (hu) | 2021-08-30 |
| FI3909972T3 (fi) | 2024-05-03 |
| EP4349854A2 (en) | 2024-04-10 |
| PT3310805T (pt) | 2021-05-19 |
| US20190010207A1 (en) | 2019-01-10 |
| DK3909972T5 (da) | 2024-08-05 |
| AU2016277883B2 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3909972T3 (da) | Pd1-cd28-fusionsproteiner og disses anvendelse i medicin | |
| DK3505519T3 (da) | Pyridinamin-substituerede heterotricyclo-forbindelser, fremstilling deraf og anvendelse i medicin | |
| DK3235830T3 (da) | Interleukin-15-proteinkompleks og anvendelse deraf | |
| DK3378859T3 (da) | Benzofuranderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i medicin | |
| DK3283106T3 (da) | Terapeutiske antistoffer og anvendelser deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3368554T3 (da) | Langtidsvirkende fgf21-fusionsproteiner og farmaceutisk sammensætning omfattende samme | |
| DK3354661T3 (da) | Fuldstændigt humant antistof mod human CD137 og anvendelse deraf | |
| DK3256468T3 (da) | Tricykliske forbindelser og anvendelser deraf i lægemidler | |
| DK3157571T3 (da) | Fedtsyrer og deres anvendelse i konjugation med biomolekyler | |
| DK3280727T3 (da) | Enkeltarmede type i- og type ii-receptorfusionsproteiner og anvendelser deraf | |
| DK3368655T3 (da) | Forbedret proteinekspression og fremgangsmåder dertil | |
| DK3345587T3 (da) | Beholderholdeelement og medicinsk beholdersæt | |
| DK3275895T3 (da) | Neuropilin-1-specifikt bindingspeptid, fusionsprotein fusioneret dermed, og anvendelse deraf | |
| DK3240436T3 (da) | Sammensætning indeholdende kitin og fordøjelige proteiner | |
| DK3290441T3 (da) | Rgma-bindingsprotein og anvendelse deraf | |
| DK3322734T3 (da) | Multivalente og multispecifikke DR5-bindende fusionsproteiner | |
| DK3100050T3 (da) | Immobiliserede proteiner og anvendelse deraf | |
| DK3204085T3 (da) | Hus og lægemiddeladministrationsanordning hermed | |
| DK3152296T3 (da) | Human hepatisk 3d-samkulturmodel og anvendelser deraf | |
| DK2983704T3 (da) | Fusionspolypeptider og vacciner | |
| DK3275453T3 (da) | Farmaceutisk sammensætning med silibinin og ve | |
| DK3057979T3 (da) | Proteiner med diagnostiske og terapeutiske anvendelser | |
| DK3110837T3 (da) | Tatk-cdkl5-fusionsproteiner, sammensætninger, formule-ringer og anvendelse deraf |